MedTrace Logo

Nutrition Supplement for Cystic Fibrosis

NCT07163078 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-19

No results posted yet for this study

Summary

The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical versions of certain nutrients outperform typical versions of these nutrients? This will be determined by examining blood measures of nutrient levels and/or indications of nutrient function indicators pre- and post-intervention. Participants will take the supplements for 6 weeks with a blood draw before and after that time.

Conditions

  • Cystic Fibrosis (CF)

Interventions

DIETARY_SUPPLEMENT

Common form supplementation

The intervention product would represent part of a typical supplement given to people including those with CF

DIETARY_SUPPLEMENT

Uncommon nutrient supplementation

The intervention product would represent part of a possible new supplement given to people including those with CF

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Robert A Emeritus Professor · Ohio State University

  • Karen Faculty Pulmonary Medicine Nationwide Children's Hospital · Nationwide Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2026-03-28
Completion
2026-04-27

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07163078 on ClinicalTrials.gov